These results indicate that the combination of IgG-IL2v with CEA TCB and FAP TCB enhances T cell infiltration and target-specific T cell cross-linking and retention into the spheroids as compared with TCB therapy alone, resulting in faster and more efficient elimination of tumor cells or fibroblasts bearing the target. Here, CEACAM5 is linked to neoplasm.